In exploring the connection between GPNMB and the PYK2/RSK2 signaling axis in GSCs, we observed that the expression of CD44 in GSCs/GBM cells is positively correlated with GPNMB expression in TAMs of tumors from patients with GBM. This evidence concerns the gene CD44 and glioblastoma.